Daniel K. Fox

2.5k total citations
23 papers, 1.3k citations indexed

About

Daniel K. Fox is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Daniel K. Fox has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in Daniel K. Fox's work include Muscle Physiology and Disorders (10 papers), Cardiomyopathy and Myosin Studies (5 papers) and Adipose Tissue and Metabolism (4 papers). Daniel K. Fox is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Cardiomyopathy and Myosin Studies (5 papers) and Adipose Tissue and Metabolism (4 papers). Daniel K. Fox collaborates with scholars based in United States, United Kingdom and Japan. Daniel K. Fox's co-authors include Christopher M. Adams, Scott M. Ebert, Kale S. Bongers, Steven D. Kunkel, Steven A. Bullard, Michael C. Dyle, Jason M. Dierdorff, Manish Suneja, Richard K. Shields and Fariborz Alipour and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Daniel K. Fox

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel K. Fox United States 12 874 486 227 147 128 23 1.3k
Hayley M. O’Neill Australia 17 1.4k 1.7× 917 1.9× 169 0.7× 499 3.4× 107 0.8× 24 2.2k
Pascal Sirvent France 20 478 0.5× 428 0.9× 307 1.4× 154 1.0× 142 1.1× 43 1.5k
Annie Durand France 15 986 1.1× 767 1.6× 331 1.5× 378 2.6× 82 0.6× 25 1.7k
Susan A. Marsh United States 24 809 0.9× 353 0.7× 170 0.7× 105 0.7× 193 1.5× 49 1.6k
Valeria De Nigris Spain 19 647 0.7× 445 0.9× 65 0.3× 201 1.4× 44 0.3× 26 1.6k
Adriana Monroy Mexico 14 538 0.6× 318 0.7× 73 0.3× 144 1.0× 47 0.4× 27 984
Mohammad Reza Alipour Iran 21 391 0.4× 272 0.6× 66 0.3× 175 1.2× 33 0.3× 112 1.4k
Meghan Kelly United States 19 761 0.9× 593 1.2× 105 0.5× 352 2.4× 221 1.7× 38 1.7k
Takeshi Yoshizaki Japan 19 1.0k 1.1× 669 1.4× 138 0.6× 474 3.2× 34 0.3× 25 2.1k
Arild C. Rustan Norway 23 739 0.8× 682 1.4× 223 1.0× 204 1.4× 79 0.6× 57 1.5k

Countries citing papers authored by Daniel K. Fox

Since Specialization
Citations

This map shows the geographic impact of Daniel K. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Fox more than expected).

Fields of papers citing papers by Daniel K. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Fox. The network helps show where Daniel K. Fox may publish in the future.

Co-authorship network of co-authors of Daniel K. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K. Fox. A scholar is included among the top collaborators of Daniel K. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K. Fox. Daniel K. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lumry, William R., et al.. (2025). Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years. International Archives of Allergy and Immunology. 187(3). 289–298.
2.
Craig, Timothy, Alan P. Baptist, John Anderson, et al.. (2025). Hereditary angioedema. Annals of Allergy Asthma & Immunology. 134(4). 465–473.e3. 1 indexed citations
3.
Lumry, William R., Mark Davis‐Lorton, Daniel Soteres, et al.. (2024). Real-World Treatment Outcomes in Patients With Hereditary Angioedema Receiving Lanadelumab or Other Long-Term Prophylaxis. Journal of Allergy and Clinical Immunology. 153(2). AB75–AB75. 1 indexed citations
4.
Dorman, Steve M., Donald McNeil, Lucy Howard, et al.. (2024). Understanding the Impact of Long-Term Prophylaxis Switches for Patients With Hereditary Angioedema. Journal of Allergy and Clinical Immunology. 153(2). AB362–AB362.
5.
Fox, Daniel K., et al.. (2023). The Association of the UNOS Heart Allocation Policy Change With Transplant and Left Ventricular Assist Device Access and Outcomes. The American Journal of Cardiology. 204. 392–400. 4 indexed citations
6.
Fox, Daniel K., et al.. (2023). Variation in the Use of Targeted Temperature Management for Cardiac Arrest. The American Journal of Cardiology. 201. 25–33. 2 indexed citations
7.
Fox, Daniel K., et al.. (2023). Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States. Journal of the American Heart Association. 12(11). e029930–e029930. 3 indexed citations
8.
Fox, Daniel K., et al.. (2021). Blunt Abdominal Trauma in the Third Trimester: Eight Departments, Two Patients, One Survivor. Cureus. 13(7). e16688–e16688. 2 indexed citations
9.
Hammond, Gmerice, et al.. (2021). Changes In Non-COVID-19 Emergency Department Visits By Acuity And Insurance Status During The COVID-19 Pandemic. Health Affairs. 40(6). 896–903. 20 indexed citations
10.
Davidson, Kevin, et al.. (2019). Outbreak of Electronic-Cigarette–Associated Acute Lipoid Pneumonia — North Carolina, July–August 2019. MMWR Morbidity and Mortality Weekly Report. 68(36). 784–786. 127 indexed citations
11.
Ebert, Scott M., Michael C. Dyle, Steven A. Bullard, et al.. (2015). Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy. Journal of Biological Chemistry. 290(42). 25497–25511. 90 indexed citations
12.
Suneja, Manish, et al.. (2015). Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy. Translational research. 166(2). 176–187. 5 indexed citations
13.
Dyle, Michael C., Scott M. Ebert, Daniel P. Cook, et al.. (2014). Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy. Journal of Biological Chemistry. 289(21). 14913–14924. 105 indexed citations
14.
Bongers, Kale S., Daniel K. Fox, Scott M. Ebert, et al.. (2013). Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. American Journal of Physiology-Endocrinology and Metabolism. 305(7). E907–E915. 112 indexed citations
15.
Ebert, Scott M., Michael C. Dyle, Steven D. Kunkel, et al.. (2012). Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy. Journal of Biological Chemistry. 287(33). 27290–27301. 166 indexed citations
16.
Kunkel, Steven D., Christopher Elmore, Kale S. Bongers, et al.. (2012). Ursolic Acid Increases Skeletal Muscle and Brown Fat and Decreases Diet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease. PLoS ONE. 7(6). e39332–e39332. 171 indexed citations
17.
Kunkel, Steven D., Manish Suneja, Scott M. Ebert, et al.. (2012). mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass. The FASEB Journal. 26(S1). 2 indexed citations
18.
Kunkel, Steven D., Manish Suneja, Scott M. Ebert, et al.. (2011). mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass. Cell Metabolism. 13(6). 627–638. 269 indexed citations
19.
Ebert, Scott M., Alex Mas Monteys, Daniel K. Fox, et al.. (2010). The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting. Molecular Endocrinology. 24(4). 790–799. 106 indexed citations
20.
Hostager, Bruce S., Daniel K. Fox, Douglas Whitten, et al.. (2010). HOIL-1L Interacting Protein (HOIP) as an NF-κB Regulating Component of the CD40 Signaling Complex. PLoS ONE. 5(6). e11380–e11380. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hayley M. O’Neill Breakdown of academic impact, for papers by Pascal Sirvent Breakdown of academic impact, for papers by Annie Durand Breakdown of academic impact, for papers by Susan A. Marsh Breakdown of academic impact, for papers by Valeria De Nigris Breakdown of academic impact, for papers by Adriana Monroy Breakdown of academic impact, for papers by Mohammad Reza Alipour Breakdown of academic impact, for papers by Meghan Kelly Breakdown of academic impact, for papers by Takeshi Yoshizaki Breakdown of academic impact, for papers by Arild C. Rustan
Rankless by CCL
2026